| MTEN 0.0401 13.60% | OCG 0.0104 -11.86% | SOXS 2.091 -8.29% | IVP 0.0581 -29.15% | APLT 0.1015 1.60% | BNKK 4.3093 55.01% | ZSL 3.0699 9.06% | SLV 81.2251 -3.94% | SOXL 60.085 8.50% | NVDA 186.66 1.92% | PTHL 0.3983 -9.44% | TQQQ 55.35 2.82% | PCLA 0.2039 -7.74% | INTC 49.95 2.52% | JTAI 0.4932 8.49% | DVLT 0.74 3.04% | MASK 0.3 -0.17% | TSLL 18.445 2.08% | OCUL 12.0799 9.12% | SIDU 3.8793 3.45% | BYND 1.105 14.88% | SXTC 0.1011 4.98% | ASST 0.9772 -5.13% | TSM 340.925 4.22% | MSTX 4.936 -5.08% | RILY 10.34 37.14% | SQQQ 65.05 -2.82% | AMD 232.6 4.03% | QQQ 625.485 0.96% | SAFX 0.1217 -11.36% | ASBP 0.0547 -6.81% | ROLR 21.4199 14.79% | GTBP 0.7257 9.95% | BMNR 32.07 -1.79% | CGTL 3.47 38.80% | SPY 694 0.53% | CRML 16.885 -5.80% | ASNS 0.4789 9.51% | NOK 6.635 4.32% | CRWV 96.8 7.80% | ONDS 13.42 -1.03% | IBIT 54.6242 -1.47% | ETHA 25.355 -0.92% | RGTI 25.88 0.62% | MU 339.62 1.88% | GPUS 0.3182 -0.50% | RZLV 4.139 1.95% | XLE 47.29 -1.60% | GRAB 4.56 -1.51% | PLUG 2.395 1.91%

Raymond James Upgrades nCino to Strong Buy, Stock Rises 5%

Raymond James upgraded nCino Inc. (NASDAQ: NCNO) to Strong Buy from Outperform and set a $36 price target after a recent pullback it tied largely to macro concerns, with shares gaining more than 5% intra-day Monday. The firm said it saw a more compelling entry point as the company’s underlying competitive position had improved.

Expected growth drivers over the next 6–18 months included platform pricing changes (largely incremental versus fiscal 2025), retention trending back toward the historical mid-to-high-90s range, a rebound in enterprise bookings and international momentum, better mortgage activity with further upside if rates fall, and the return of bank M&A as a direct tailwind. Strong competitive positioning and rising incremental margins also underpinned the thesis, the analysts said.

While resurfacing credit risk worries in bank end-markets and broader AI uncertainty had weighed on the stock, Raymond James argued longer-term investors could benefit from today’s levels, noting valuation around ~5x revenue and ~20x EBITDA on its fiscal 2027 (≈CY26) estimates.

Published on: October 20, 2025